| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 3 |
| 1 | DUPILUMAB | 2 |
| 2 | PREDNISOLONE | 2 |
| 3 | PREDNISOLONE ORAL | 2 |
| 4 | PREDNISOLONE ORAL SOLUTION | 2 |
| 5 | RITUXIMAB | 2 |
| 6 | ATEZOLIZUMAB | 1 |
| 7 | BENDAMUSTINE HCL | 1 |
| 8 | BENDAMUSTINE HYDROCHLORIDE | 1 |
| 9 | BENRALIZUMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ELRANATAMAB-BCMM | 1 | 0.0009 |
| 1 | TEZEPELUMAB-EKKO | 1 | 0.0001 |
| 2 | BENDAMUSTINE HYDROCHLORIDE | 1 | 0.0001 |
| 3 | ITRACONAZOLE | 1 | 0.0001 |
| 4 | THEOPHYLLINE ANHYDROUS | 1 | 0.0001 |
| 5 | BENDAMUSTINE HCL | 1 | 0.0001 |
| 6 | BENRALIZUMAB | 1 | 0.0000 |
| 7 | MESALAMINE | 1 | 0.0000 |
| 8 | CLARITHROMYCIN | 1 | 0.0000 |
| 9 | PEMBROLIZUMAB | 3 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Thymic Stromal Lymphopoietin Blocker [EPC] | 1 | 0.0001 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 5 | 0.0001 |
| 3 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 4 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 5 | Macrolide Antimicrobial [EPC] | 1 | 0.0000 |
| 6 | Methylxanthine [EPC] | 1 | 0.0000 |
| 7 | Aminosalicylate [EPC] | 1 | 0.0000 |
| 8 | Interleukin-23 Antagonist [EPC] | 1 | 0.0000 |
| 9 | Sulfonylurea [EPC] | 1 | 0.0000 |